Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception

ClinicalTrials.gov ID: NCT01429116

Public ClinicalTrials.gov record NCT01429116. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 20, 2026, 12:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Extension Open-Label Safety Study of a 24-month 20 mg Dose Regimen of Tasimelteon for the Treatment of Non-24-Hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception Who Have Enrolled in Other Tasimelteon Clinical Trials

Study identification

NCT ID
NCT01429116
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Vanda Pharmaceuticals
Industry
Enrollment
200 participants

Conditions and interventions

Interventions

  • tasimelteon Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2011
Primary completion
Dec 31, 2014
Completion
Dec 31, 2014
Last update posted
Apr 20, 2015

2011 – 2015

United States locations

U.S. sites
22
U.S. states
17
U.S. cities
22
Facility City State ZIP Site status
Pulmonary Associates, PA Phoenix Arizona 85006
SDS Clinical Trials Inc. Orange California 92868
VA Palo Alto Health Care System/PAIRE (San Fransisco Bay Area) Palo Alto California 94304
St. Johns Sleep Disorder Center - St. Johns Medical Plaza Santa Monica California 90404
Radiant Research - Denver Denver Colorado 80239
PAB Clinical Research Inc. Brandon Florida 33511
Kendall South Medical Center, Inc. Miami Florida 33185
Neurology Associates of Ormond Beach Ormond Beach Florida 32174
Sleep Disorders Center Of Georgia Atlanta Georgia 30342
Suburban Lung Associates SC (Chicago Metropolitan Area) Elk Grove Village Illinois 60007
The Center for Sleep and Wake Disorders (Washington, D.C. Metropolitan Area) Chevy Chase Maryland 20815
Brigham and Women's Hospital Boston Massachusetts 02115
Michigan Head-Pain Neurological Institute Ann Arbor Michigan 48104
St. Luke's Sleep Medicine and Research Center (St. Louis Metropolitan Area) Chesterfield Missouri 63017
New York Eye and Ear Infirmary New York New York 10003
Ohio Sleep Medicine Institute (Columbus Metropolitan Area) Dublin Ohio 43017
Lynn Health Science Institute Oklahoma City Oklahoma 73112
Columbia Research Group Inc. Portland Oregon 97239
Center for Sleep Medicine at Chestnut Hill Hospital Philadelphia Pennsylvania 19118
Consolidated Clinical trials Pittsburgh Pennsylvania 15221
SleepMed, Inc. - Columbia Columbia South Carolina 29201
Todd J. Swick, M.D., P.A. Houston Texas 77063

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01429116, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 20, 2015 · Synced Jul 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01429116 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →